Stop Chemo Damage with This All-Natural “Grain Shield”

It’s been the dirty secret in cancer treatment for decades…

Many cancer patients don’t die from cancer at all—they die from infections.

And it’s easy to see how…

If you or a loved one has ever been through grueling rounds of chemotherapy, you know that it can send your white blood cell, red blood cell, and platelet counts crashing.

That’s because chemotherapy doesn’t just attack cancer… it attacks you and your entire immune system.

The next thing you know, you’re a sitting duck for a potentially deadly infection.

But researchers have just discovered something remarkable… a “grain shield” that can actually protect your immune system from the worst effects of chemo.

And even better? It might make cancer cells more vulnerable to treatment

The “grain shield” is IP6 plus inositol—also called inositol hexaphosphate—a naturally occurring substance found in rice bran and other whole grains.

For decades, researchers have known IP6 has protective effects on cells. It’s concentrated in seeds and grains, where it safeguards their genetic material.

Croatian researchers wondered: Could this protection extend to bone marrow during chemotherapy?

They designed a pilot study with 14 breast cancer patients undergoing chemotherapy for invasive ductal carcinoma. Seven received IP6 plus inositol during treatment cycles. Seven received standard care only.

At the end of the study, the IP6 group had no dangerous drops in blood cell counts. Their white blood cells stayed stable. Platelets stayed stable. Red blood cells maintained throughout treatment.

Every single patient in the treatment group completed chemotherapy on schedule. No delays. No dose reductions. No interruptions.

The control group? Standard pattern. Blood counts crashed. Treatment delays. Reduced quality of life.

A 2021 follow-up study tracked 36 breast cancer patients through chemotherapy. Half received IP6 plus inositol. Half didn’t.

The inositol group showed significantly smaller decreases in red blood cells, hemoglobin, and white blood cells.

More importantly, they felt better. The difference wasn’t just in lab values—it was in patients’ ability to function, to feel human, to maintain some semblance of normal life while fighting cancer.

But IP6 plus inositol doesn’t just protect you from some of the worst effects of cancer treatment… it may actually help you fight cancer.

Research shows it sensitizes cancer cells to treatment, making them MORE susceptible.

Studies even show IP6 has its own anti-cancer properties—inhibiting cancer cell growth and triggering programmed death in malignant cells.

It’s selective protection. The cancer stays exposed to treatment. Your healthy tissue gets shielded.

Most oncologists have never heard of IP6 plus inositol. It won’t be suggested alongside your treatment plan.

But when you’re fighting cancer, you don’t have the luxury of waiting for medicine to update the playbook.

IP6 plus inositol supplements are widely available. The Croatian studies used oral supplementation during chemotherapy cycles. Typical doses range from 1-2 grams of IP6 with 200-400 mg of inositol (though exact protocols should be discussed with your oncology team).

This isn’t a cancer treatment. It’s protective support during aggressive therapy. Anyone considering it should coordinate with their oncologist—timing with treatment cycles matters and potential interactions are all important to discuss.

But here’s the question worth asking: If you could protect your healthy cells from treatment damage while making cancer cells more vulnerable, why wouldn’t you explore it?

The goal isn’t just to destroy cancer cells. It’s to destroy them while keeping you strong enough to survive the battle.

To protecting what matters while fighting what doesn’t,

Rachel Mace
Managing Editorial Director, e-Alert
with contributions from the research team

Sources:

• Bačić I, Druzijanić N, Karlo R, et al. Efficacy of IP6 + inositol in the treatment of breast cancer patients receiving chemotherapy: prospective, randomized, pilot clinical study. Journal of Experimental & Clinical Cancer Research. 2010;29:12. https://pubmed.ncbi.nlm.nih.gov/20152024/
• Amabile MI, Belardi M, Di Bartolomeo M, et al. Effects of Inositol Hexaphosphate and Myo-Inositol Administration in Breast Cancer Patients during Adjuvant Chemotherapy. Nutrients. 2021;13(8):2712. https://pubmed.ncbi.nlm.nih.gov/34442400/